Skip to content
Peptigraph home

Sermorelin for Testosterone: What the Evidence Shows

What human and animal studies show about Sermorelin for testosterone, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGHRH analogUpdated
Strongest evidence
Human observational
Human studies
2
PubMed records, our ledger
Animal studies
0
PubMed records, our ledger
Studies we summarised
1
with an outcome for testosterone

Evidence for testosterone

Each row is an outcome related to testosterone from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Sermorelin for testosterone: outcomes in published studies
OutcomeResultStudy typeSource
Serum IGF-1Mean IGF-1 rose from 159.5 ng/mL at baseline to 239.0 ng/mL after combined GHRP/sermorelin therapy (retrospective, multi-peptide combination, no control).Human observationaln = 14American journal of men's health 2017, PMID 28830317

PubMed records for Sermorelin and testosterone: 2 human, 0 animal (search counts, not studies we reviewed). Grades follow our .

How strong is it?

Strongest evidence:Human observational evidence, 3 of 4American journal of men's health 2017, PMID 28830317

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Testosterone and the test that measures it

MedlinePlus explains that most testosterone in blood is bound to proteins such as SHBG and albumin, and bound testosterone cannot be used as easily by the body.[2]

Sermorelin and testosterone: what exists

The testosterone, hypogonadism or androgen-deficiency query for sermorelin or Geref (run 2026-10-02) found 2 human records, 0 animal records and 0 randomized trials among 3 in all.

Calculated from human 2; human only 2; animal 0; rct 0; all 3. Formula: Counts copied from the sermorelin ledger row of the testosterone goal in goals.json; no arithmetic.

The main paper is a chart review of men already on testosterone therapy who were prescribed sermorelin with GHRP-6 and GHRP-2. Its reported outcome was IGF-1, which rose.[1]

It also noted that men on an aromatase inhibitor or tamoxifen had smaller IGF-1 rises.[1]

In a study of GHRH injections in healthy old and young men, baseline testosterone was lower in the older men.[3]

What the study design cannot tell you

Of 105 men prescribed the combination, only 14 met strict inclusion criteria for compliance.[1]

A clinical review reports that Geref was discontinued in July 2008.[4]

Other peptides people research for testosterone

All peptides for testosterone, compared

Common questions

Does Sermorelin help with testosterone?

The strongest study we summarise for testosterone is human observational evidence, across 1 study with an outcome for testosterone. That is not proof it works in people.

Is Sermorelin approved for testosterone?

No. Sermorelin is not FDA approved for any use, including testosterone.

What is the best peptide for testosterone?

There is no single answer. Our testosterone overview compares each candidate by evidence grade and legal status rather than by popularity.

Does sermorelin increase testosterone?

None of the cached sources reports sermorelin raising testosterone. The chart review in men already on testosterone therapy reports IGF-1 rising.[1]

Can sermorelin treat low testosterone?

No cached study tested sermorelin as a treatment for low testosterone. The one chart review gave it to men who were already on testosterone therapy.[1]

Has sermorelin been studied in men on testosterone therapy?

Once: a chart review of men already on testosterone therapy who were prescribed sermorelin together with GHRP-6 and GHRP-2. It reported IGF-1 and was not an interaction or safety study.[1]

More on Sermorelin

Sources

  1. 1Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.American journal of men's health · 2017PMID 28830317Accessed 2 Oct 2026
  2. 2Official web pageOfficial web page · web page
  3. 3Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.The Journal of clinical endocrinology and metabolism · 1992PMID 1379256Accessed 2 Oct 2026
  4. 4Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?The Journal of clinical endocrinology and metabolism · 2009PMID 19509104Accessed 2 Oct 2026

Found an error? Report a correction.